Bertil Glader

Stanford Medicine Professor of Pediatric Hematology/Oncology and Professor, by courtesy, of Pathology

Clinical Focus

Pediatric Hematology-Oncology

Academic Appointments

Professor, Pediatrics - Hematology & Oncology
Professor (By courtesy), Pathology
Member, Maternal & Child Health Research Institute (MCHRI)

Administrative Appointments

Instructor in Pediatrics, Harvard Medical School (1973 - 1974)
Assistant Professor of Pediatrics, Harvard Medical School (1974 - 1977)
Associate Professor of Pediatrics, Stanford University (1977 - 1987)
Professor of Pediatrics, Stanford University (1987 - Present)

Professional Education

Internship: Stanford Health Care at Lucile Packard Children's Hospital (1969) CA
Fellowship: Boston Childrens Hospital Pediatric Hematology and Oncology Fellowship (1974) MA
Residency: Children's Hospital Boston Medical Center Pediatric Residency (1973) MA
Medical Education: Northwestern University Feinberg School of Medicine (1968) IL
Board Certification: American Board of Pediatrics, Pediatrics (1982)
Board Certification: American Board of Pediatrics, Pediatric Hematology-Oncology (1982)
Board Certification: American Board of Pathology, Hematology (1983)
BA, Northwestern University, Philosophy (1961)
PhD, University of Illinois, Physiology (1967)
MD, Northwestern University, Medicine (1968)

Contact

Academic bglader@stanford.edu Tel: (650) 723-5152Tel: (650) 723-5535 Fax: (650) 723-5231

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Bass Cancer Center for Childhood Cancer and Blood Diseases 725 Welch Rd MC 5913 Palo Alto CA 94304 Tel: (650) 497-8953 Fax: (650) 725-3219

Additional Clinical Info

Stanford Medicine Children's Health

Current Research and Scholarly Interests

Hematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary red blood cell disorders-clinical trials.

Clinical Trials

Pyruvate Kinase Deficiency Natural History Study Not Recruiting
More
The purpose of this study is to describe the range and incidence of symptoms, treatments, and complications related to pyruvate kinase deficiency (PKD). Eligible patients are those of all ages with known PKD or with a hemolytic anemia and a family member with PKD. The study will collect retrospective medical history, routine clinical care data, and quality of life measures at baseline and annually for patients with PKD.

Stanford is currently not accepting patients for this trial. For more information, please contact Heather Hilmoe, CRA, 650-725-1662.
Lead Sponsor
Stanford Investigators
- Bertil Glader
View full details
A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency Not Recruiting
More
Study AG348-C-003 is a multicenter study designed to evaluate the safety and efficacy of different dose levels of AG-348 (mitapivat) in participants with PK deficiency.

Stanford is currently not accepting patients for this trial. For more information, please contact Heather Hilmoe, 650-725-1662.
Lead Sponsor
Stanford Investigators
- Bertil Glader
View full details

2024-25 Courses

Independent Studies
- Directed Reading in Pediatrics
  PEDS 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience
  PEDS 280 (Aut, Win, Spr, Sum)
- Graduate Research
  PEDS 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  PEDS 370 (Aut, Win, Spr, Sum)
- Undergraduate Directed Reading/Research
  PEDS 199 (Aut, Win, Spr, Sum)